OTCMKTS:VBIO - Vitality Biopharma Stock Price, Price Target & More

Sign in or create an account to add this stock to your watchlist.
$1.70 +0.18 (+11.84 %)
(As of 06/22/2018 05:02 AM ET)
Previous Close$1.52
Today's Range$1.53 - $1.76
52-Week Range$1.05 - $2.37
Volume334,709 shs
Average Volume128,266 shs
Market Capitalization$31.59 million
P/E RatioN/A
Dividend YieldN/A
Beta1.02
Vitality Biopharma, Inc. focuses on the development of cannabinoid pharmaceuticals for the treatment of neurological and inflammatory disorders in the United States. Its products in pipeline include VITA-100, an oral cannabinoid formulation that is used for the acute treatment of inflammatory bowel disease and narcotic bowel syndrome; and VITA-210, a cannabinoid formulation, which is in preclinical studies for use in the chronic treatment of neuropathic pain, irritable bowel syndrome, muscle spasticity in multiple sclerosis, and opioid-induced bowel dysfunction. The company was formerly known as Stevia First Corp. and changed its name to Vitality Biopharma, Inc. in July 2016. Vitality Biopharma, Inc. was founded in 2007 and is based in Los Angeles, California.

Receive VBIO News and Ratings via Email

Sign-up to receive the latest news and ratings for VBIO and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry Commercial physical research
Sub-IndustryN/A
SectorMedical
SymbolOTCMKTS:VBIO
CUSIPN/A
Phone530-231-7800

Debt

Debt-to-Equity RatioN/A
Current Ratio3.54
Quick Ratio3.54

Price-To-Earnings

Trailing P/E RatioN/A
Forward P/E RatioN/A
P/E GrowthN/A

Sales & Book Value

Annual Sales$160,000.00
Price / Sales243.21
Cash FlowN/A
Price / CashN/A
Book Value$0.02 per share
Price / Book85.00

Profitability

EPS (Most Recent Fiscal Year)N/A
Net Income$-5,210,000.00
Net Margins-4,403.03%
Return on Equity-1,227.89%
Return on Assets-443.66%

Miscellaneous

Employees7
Outstanding Shares22,890,000

Vitality Biopharma (OTCMKTS:VBIO) Frequently Asked Questions

What is Vitality Biopharma's stock symbol?

Vitality Biopharma trades on the OTCMKTS under the ticker symbol "VBIO."

Who are some of Vitality Biopharma's key competitors?

Who are Vitality Biopharma's key executives?

Vitality Biopharma's management team includes the folowing people:
  • Mr. Robert T. Brooke, CEO, Sec., Treasurer & Director (Age 38)
  • Dr. Brandon J. Zipp Ph.D., Scientific Co-Founder and Director of R&D
  • Dr. J. Jeremiah Mann Ph.D., VP of Operations and Sr. Agronomist
  • Mr. Richard McKilligan, Controller (Age 54)
  • Dr. Dong Yuejin, Partner

Has Vitality Biopharma been receiving favorable news coverage?

News stories about VBIO stock have trended positive on Friday, Accern Sentiment reports. Accern identifies negative and positive press coverage by monitoring more than twenty million news and blog sources. Accern ranks coverage of publicly-traded companies on a scale of -1 to 1, with scores nearest to one being the most favorable. Vitality Biopharma earned a news impact score of 0.31 on Accern's scale. They also assigned news headlines about the company an impact score of 45.44 out of 100, indicating that recent press coverage is somewhat unlikely to have an effect on the stock's share price in the next few days.

How do I buy shares of Vitality Biopharma?

Shares of VBIO can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Vitality Biopharma's stock price today?

One share of VBIO stock can currently be purchased for approximately $1.70.

How big of a company is Vitality Biopharma?

Vitality Biopharma has a market capitalization of $31.59 million and generates $160,000.00 in revenue each year. Vitality Biopharma employs 7 workers across the globe.

How can I contact Vitality Biopharma?

Vitality Biopharma's mailing address is 1901 AVENUE OF THE STARS 2ND FLOOR, LOS ANGELES CA, 90067. The company can be reached via phone at 530-231-7800 or via email at [email protected]


MarketBeat Community Rating for Vitality Biopharma (VBIO)

Community Ranking:  2.7 out of 5 (star star)
Outperform Votes:  58 (Vote Outperform)
Underperform Votes:  49 (Vote Underperform)
Total Votes:  107
MarketBeat's community ratings are surveys of what our community members think about Vitality Biopharma and other stocks. Vote "Outperform" if you believe VBIO will outperform the S&P 500 over the long term. Vote "Underperform" if you believe VBIO will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 6/22/2018 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.